1. Thienopyridine derivatives identified as the first selective, full efficacy, dopamine D1 receptor agonists;Andersen;Eur J Pharmacol,1987
2. The selective dopamine D1 receptor agonist A-86929 maintains efficacy with repeated treatment in rodent and animal primate models of Parkinson's disease;Asin;J Pharmacol Exp Ther,1997
3. The pharmacokinetics and safety of a selective dopamine D1 receptor agonist, A-86929, after intravenous administration of ABT-431 to Parkinson's disease patients;Bertz;Pharm Res,1997
4. Selective D1 dopamine receptor agonist treatment of Parkinson's disease;Braun;J Neural Trans,1987
5. D1 dopamine receptor agonists indice forelimb clonus;Britton;Soc Neurosci Abstr,1991